Insights into the possible role of IFNG and IFNGR1 in Kala-azar and Post Kala-azar Dermal Leishmaniasis in Sudanese patients
Little is known about the parasite/host factors that lead to Post Kala-azar Dermal Leishmaniasis (PKDL) in some visceral leishmaniasis (VL) patients after drug-cure. Studies in Sudan provide evidence for association between polymorphisms in the gene (IFNGR1) encoding the alpha chain of interferon-γ...
Gespeichert in:
Veröffentlicht in: | BMC infectious diseases 2014-12, Vol.14 (1), p.662-662, Article 662 |
---|---|
Hauptverfasser: | , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 662 |
---|---|
container_issue | 1 |
container_start_page | 662 |
container_title | BMC infectious diseases |
container_volume | 14 |
creator | Salih, Mohamed A M Fakiola, Michaela Abdelraheem, Mohamed H Younis, Brima M Musa, Ahmed M ElHassan, Ahmed M Blackwell, Jenefer M Ibrahim, Muntaser E Mohamed, Hiba S |
description | Little is known about the parasite/host factors that lead to Post Kala-azar Dermal Leishmaniasis (PKDL) in some visceral leishmaniasis (VL) patients after drug-cure. Studies in Sudan provide evidence for association between polymorphisms in the gene (IFNGR1) encoding the alpha chain of interferon-γ receptor type I and risk of PKDL. This study aimed to identify putative functional polymorphisms in the IFNGR1 gene, and to determine whether differences in expression of interferon-γ (IFNG) and IFNGR1 at the RNA level are associated with pathogenesis of VL and/or PKDL in Sudan.
Sanger sequencing was used to re-sequence 841 bp of upstream, exon1 and intron1 of the IFNGR1 gene in DNA from 30 PKDL patients. LAGAN and SYNPLOT bioinformatics tools were used to compare human, chimpanzee and dog sequences to identify conserved noncoding sequences carrying putative regulatory elements. The relative expression of IFNG and IFNGR1 in paired pre- and post-treatment RNA samples from the lymph nodes of 24 VL patients, and in RNA samples from skin biopsies of 19 PKDL patients, was measured using real time PCR. Pre- versus post-treatment expression was evaluated statistically using the nonparametric Wilcoxon matched pairs signed-rank test.
Ten variants were identified in the 841 bp of sequence, four of which are novel polymorphisms at -77A/G, +10 C/T, +18C/T and +91G/T relative to the IFNGR1 initiation site. A cluster of conserved non-coding sequences with putative regulatory variants was identified in the distal promoter of IFNGR1. Variable expression of IFNG was detected in lymph node aspirates of VL patients before treatment, with a marked reduction (P = 0.006) in expression following treatment. IFNGR1 expression was also variable in lymph node aspirates from VL patients, with no significant reduction in expression with treatment. IFNG expression was undetectable in the skin biopsies of PKDL cases, while IFNGR1 expression was also uniformly low.
Uniformly low expression of IFN and IFNGR1 in PKDL skin biopsies could explain parasite persistence and is consistent with prior demonstration of genetic association with IFNGR1 polymorphisms. Identification of novel potentially functional rare variants at IFNGR1 makes an important general contribution to knowledge of rare variants of potential relevance in this Sudanese population. |
doi_str_mv | 10.1186/s12879-014-0662-5 |
format | Article |
fullrecord | <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4265480</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A539574900</galeid><sourcerecordid>A539574900</sourcerecordid><originalsourceid>FETCH-LOGICAL-b656t-936eb6cf1c0b9664e31a63b54c3c329cc6216a4fde071738dc2cb1e5183f7a03</originalsourceid><addsrcrecordid>eNqNkk1v1DAQhiMEoh_wA7igSFzoIcVjx3ZyQapaWlasKGorrpbjOLuuEntrOwgQPx6nW8ouKlJlKbbGz7zjzDtZ9grQIUDF3gXAFa8LBGWBGMMFfZLtQsmhwISUTzfOO9leCNcIAa9w_TzbwbRkrMbVbvZrZoNZLGPIjY0uj0udr1wIpul17l36uC6fnX4-y6Vtbw8XkMj8k-xlIX9Kfxv_4kLcCJ1oP8g-n2sTloO0RgYzyeeXYyutDqmCjEbbGF5kzzrZB_3ybt_Prk4_XB1_LObnZ7Pjo3nRMMpiUROmG6Y6UKipGSs1AclIQ0tFFMG1UgwDk2XXasSBk6pVWDWgKVSk4xKR_ez9WnY1NoNuVSrtZS9W3gzS_xBOGrF9Y81SLNw3UWJGy2oSOFkLNMb9R2D7RrlBrM0RyRwxmSNoknl79w7vbkYdohhMULrvU1fcGAQwzgmnwNEj0OQgBwYkoW_-Qa_d6G3qZ6IIrTlPv_GXWsheC2M7lx6qJlFxRElNeVmjqezhA1RarR6MclZ3JsW3Eg62EhIT9fe4kGMIYnZ58Xj2_Os2C2tW-TSNXnf3zQYkptl_sL2vN22-z_gz7OQ3ihP79Q</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1635977426</pqid></control><display><type>article</type><title>Insights into the possible role of IFNG and IFNGR1 in Kala-azar and Post Kala-azar Dermal Leishmaniasis in Sudanese patients</title><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><source>SpringerLink Journals - AutoHoldings</source><source>PubMed Central Open Access</source><source>Springer Nature OA Free Journals</source><creator>Salih, Mohamed A M ; Fakiola, Michaela ; Abdelraheem, Mohamed H ; Younis, Brima M ; Musa, Ahmed M ; ElHassan, Ahmed M ; Blackwell, Jenefer M ; Ibrahim, Muntaser E ; Mohamed, Hiba S</creator><creatorcontrib>Salih, Mohamed A M ; Fakiola, Michaela ; Abdelraheem, Mohamed H ; Younis, Brima M ; Musa, Ahmed M ; ElHassan, Ahmed M ; Blackwell, Jenefer M ; Ibrahim, Muntaser E ; Mohamed, Hiba S</creatorcontrib><description>Little is known about the parasite/host factors that lead to Post Kala-azar Dermal Leishmaniasis (PKDL) in some visceral leishmaniasis (VL) patients after drug-cure. Studies in Sudan provide evidence for association between polymorphisms in the gene (IFNGR1) encoding the alpha chain of interferon-γ receptor type I and risk of PKDL. This study aimed to identify putative functional polymorphisms in the IFNGR1 gene, and to determine whether differences in expression of interferon-γ (IFNG) and IFNGR1 at the RNA level are associated with pathogenesis of VL and/or PKDL in Sudan.
Sanger sequencing was used to re-sequence 841 bp of upstream, exon1 and intron1 of the IFNGR1 gene in DNA from 30 PKDL patients. LAGAN and SYNPLOT bioinformatics tools were used to compare human, chimpanzee and dog sequences to identify conserved noncoding sequences carrying putative regulatory elements. The relative expression of IFNG and IFNGR1 in paired pre- and post-treatment RNA samples from the lymph nodes of 24 VL patients, and in RNA samples from skin biopsies of 19 PKDL patients, was measured using real time PCR. Pre- versus post-treatment expression was evaluated statistically using the nonparametric Wilcoxon matched pairs signed-rank test.
Ten variants were identified in the 841 bp of sequence, four of which are novel polymorphisms at -77A/G, +10 C/T, +18C/T and +91G/T relative to the IFNGR1 initiation site. A cluster of conserved non-coding sequences with putative regulatory variants was identified in the distal promoter of IFNGR1. Variable expression of IFNG was detected in lymph node aspirates of VL patients before treatment, with a marked reduction (P = 0.006) in expression following treatment. IFNGR1 expression was also variable in lymph node aspirates from VL patients, with no significant reduction in expression with treatment. IFNG expression was undetectable in the skin biopsies of PKDL cases, while IFNGR1 expression was also uniformly low.
Uniformly low expression of IFN and IFNGR1 in PKDL skin biopsies could explain parasite persistence and is consistent with prior demonstration of genetic association with IFNGR1 polymorphisms. Identification of novel potentially functional rare variants at IFNGR1 makes an important general contribution to knowledge of rare variants of potential relevance in this Sudanese population.</description><identifier>ISSN: 1471-2334</identifier><identifier>EISSN: 1471-2334</identifier><identifier>DOI: 10.1186/s12879-014-0662-5</identifier><identifier>PMID: 25466928</identifier><language>eng</language><publisher>England: BioMed Central Ltd</publisher><subject>Adolescent ; Adult ; Analysis ; Biological response modifiers ; Biopsy ; Child ; Child, Preschool ; Data analysis ; Distribution ; Female ; Gene expression ; Genes ; Genetic aspects ; Genetic polymorphisms ; Haplotypes ; Health risk assessment ; Humans ; Infections ; Interferon ; Interferon gamma Receptor ; Interferon-gamma - genetics ; Laboratories ; Leishmaniasis, Cutaneous - etiology ; Leishmaniasis, Cutaneous - genetics ; Leishmaniasis, Visceral - complications ; Leishmaniasis, Visceral - genetics ; Lymphatic system ; Malaria ; Male ; Medical research ; Medicine, Experimental ; Pan troglodytes ; Parasites ; Parasitic diseases ; Pathogenesis ; Polymorphism, Genetic ; Population ; Promoter Regions, Genetic ; Rankings ; Receptors, Interferon - genetics ; RNA ; RNA, Messenger - metabolism ; Signal transduction ; Skin ; Skin - metabolism ; Studies ; Sudan - epidemiology ; Tropical diseases ; Tuberculosis ; Young Adult</subject><ispartof>BMC infectious diseases, 2014-12, Vol.14 (1), p.662-662, Article 662</ispartof><rights>COPYRIGHT 2014 BioMed Central Ltd.</rights><rights>2014 Salih et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.</rights><rights>Salih et al.; licensee BioMed Central Ltd. 2014</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-b656t-936eb6cf1c0b9664e31a63b54c3c329cc6216a4fde071738dc2cb1e5183f7a03</citedby><cites>FETCH-LOGICAL-b656t-936eb6cf1c0b9664e31a63b54c3c329cc6216a4fde071738dc2cb1e5183f7a03</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4265480/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4265480/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,860,881,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25466928$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Salih, Mohamed A M</creatorcontrib><creatorcontrib>Fakiola, Michaela</creatorcontrib><creatorcontrib>Abdelraheem, Mohamed H</creatorcontrib><creatorcontrib>Younis, Brima M</creatorcontrib><creatorcontrib>Musa, Ahmed M</creatorcontrib><creatorcontrib>ElHassan, Ahmed M</creatorcontrib><creatorcontrib>Blackwell, Jenefer M</creatorcontrib><creatorcontrib>Ibrahim, Muntaser E</creatorcontrib><creatorcontrib>Mohamed, Hiba S</creatorcontrib><title>Insights into the possible role of IFNG and IFNGR1 in Kala-azar and Post Kala-azar Dermal Leishmaniasis in Sudanese patients</title><title>BMC infectious diseases</title><addtitle>BMC Infect Dis</addtitle><description>Little is known about the parasite/host factors that lead to Post Kala-azar Dermal Leishmaniasis (PKDL) in some visceral leishmaniasis (VL) patients after drug-cure. Studies in Sudan provide evidence for association between polymorphisms in the gene (IFNGR1) encoding the alpha chain of interferon-γ receptor type I and risk of PKDL. This study aimed to identify putative functional polymorphisms in the IFNGR1 gene, and to determine whether differences in expression of interferon-γ (IFNG) and IFNGR1 at the RNA level are associated with pathogenesis of VL and/or PKDL in Sudan.
Sanger sequencing was used to re-sequence 841 bp of upstream, exon1 and intron1 of the IFNGR1 gene in DNA from 30 PKDL patients. LAGAN and SYNPLOT bioinformatics tools were used to compare human, chimpanzee and dog sequences to identify conserved noncoding sequences carrying putative regulatory elements. The relative expression of IFNG and IFNGR1 in paired pre- and post-treatment RNA samples from the lymph nodes of 24 VL patients, and in RNA samples from skin biopsies of 19 PKDL patients, was measured using real time PCR. Pre- versus post-treatment expression was evaluated statistically using the nonparametric Wilcoxon matched pairs signed-rank test.
Ten variants were identified in the 841 bp of sequence, four of which are novel polymorphisms at -77A/G, +10 C/T, +18C/T and +91G/T relative to the IFNGR1 initiation site. A cluster of conserved non-coding sequences with putative regulatory variants was identified in the distal promoter of IFNGR1. Variable expression of IFNG was detected in lymph node aspirates of VL patients before treatment, with a marked reduction (P = 0.006) in expression following treatment. IFNGR1 expression was also variable in lymph node aspirates from VL patients, with no significant reduction in expression with treatment. IFNG expression was undetectable in the skin biopsies of PKDL cases, while IFNGR1 expression was also uniformly low.
Uniformly low expression of IFN and IFNGR1 in PKDL skin biopsies could explain parasite persistence and is consistent with prior demonstration of genetic association with IFNGR1 polymorphisms. Identification of novel potentially functional rare variants at IFNGR1 makes an important general contribution to knowledge of rare variants of potential relevance in this Sudanese population.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Analysis</subject><subject>Biological response modifiers</subject><subject>Biopsy</subject><subject>Child</subject><subject>Child, Preschool</subject><subject>Data analysis</subject><subject>Distribution</subject><subject>Female</subject><subject>Gene expression</subject><subject>Genes</subject><subject>Genetic aspects</subject><subject>Genetic polymorphisms</subject><subject>Haplotypes</subject><subject>Health risk assessment</subject><subject>Humans</subject><subject>Infections</subject><subject>Interferon</subject><subject>Interferon gamma Receptor</subject><subject>Interferon-gamma - genetics</subject><subject>Laboratories</subject><subject>Leishmaniasis, Cutaneous - etiology</subject><subject>Leishmaniasis, Cutaneous - genetics</subject><subject>Leishmaniasis, Visceral - complications</subject><subject>Leishmaniasis, Visceral - genetics</subject><subject>Lymphatic system</subject><subject>Malaria</subject><subject>Male</subject><subject>Medical research</subject><subject>Medicine, Experimental</subject><subject>Pan troglodytes</subject><subject>Parasites</subject><subject>Parasitic diseases</subject><subject>Pathogenesis</subject><subject>Polymorphism, Genetic</subject><subject>Population</subject><subject>Promoter Regions, Genetic</subject><subject>Rankings</subject><subject>Receptors, Interferon - genetics</subject><subject>RNA</subject><subject>RNA, Messenger - metabolism</subject><subject>Signal transduction</subject><subject>Skin</subject><subject>Skin - metabolism</subject><subject>Studies</subject><subject>Sudan - epidemiology</subject><subject>Tropical diseases</subject><subject>Tuberculosis</subject><subject>Young Adult</subject><issn>1471-2334</issn><issn>1471-2334</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNqNkk1v1DAQhiMEoh_wA7igSFzoIcVjx3ZyQapaWlasKGorrpbjOLuuEntrOwgQPx6nW8ouKlJlKbbGz7zjzDtZ9grQIUDF3gXAFa8LBGWBGMMFfZLtQsmhwISUTzfOO9leCNcIAa9w_TzbwbRkrMbVbvZrZoNZLGPIjY0uj0udr1wIpul17l36uC6fnX4-y6Vtbw8XkMj8k-xlIX9Kfxv_4kLcCJ1oP8g-n2sTloO0RgYzyeeXYyutDqmCjEbbGF5kzzrZB_3ybt_Prk4_XB1_LObnZ7Pjo3nRMMpiUROmG6Y6UKipGSs1AclIQ0tFFMG1UgwDk2XXasSBk6pVWDWgKVSk4xKR_ez9WnY1NoNuVSrtZS9W3gzS_xBOGrF9Y81SLNw3UWJGy2oSOFkLNMb9R2D7RrlBrM0RyRwxmSNoknl79w7vbkYdohhMULrvU1fcGAQwzgmnwNEj0OQgBwYkoW_-Qa_d6G3qZ6IIrTlPv_GXWsheC2M7lx6qJlFxRElNeVmjqezhA1RarR6MclZ3JsW3Eg62EhIT9fe4kGMIYnZ58Xj2_Os2C2tW-TSNXnf3zQYkptl_sL2vN22-z_gz7OQ3ihP79Q</recordid><startdate>20141203</startdate><enddate>20141203</enddate><creator>Salih, Mohamed A M</creator><creator>Fakiola, Michaela</creator><creator>Abdelraheem, Mohamed H</creator><creator>Younis, Brima M</creator><creator>Musa, Ahmed M</creator><creator>ElHassan, Ahmed M</creator><creator>Blackwell, Jenefer M</creator><creator>Ibrahim, Muntaser E</creator><creator>Mohamed, Hiba S</creator><general>BioMed Central Ltd</general><general>BioMed Central</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>IOV</scope><scope>ISR</scope><scope>3V.</scope><scope>7QL</scope><scope>7T2</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8C1</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>F1W</scope><scope>H95</scope><scope>H97</scope><scope>L.G</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20141203</creationdate><title>Insights into the possible role of IFNG and IFNGR1 in Kala-azar and Post Kala-azar Dermal Leishmaniasis in Sudanese patients</title><author>Salih, Mohamed A M ; Fakiola, Michaela ; Abdelraheem, Mohamed H ; Younis, Brima M ; Musa, Ahmed M ; ElHassan, Ahmed M ; Blackwell, Jenefer M ; Ibrahim, Muntaser E ; Mohamed, Hiba S</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b656t-936eb6cf1c0b9664e31a63b54c3c329cc6216a4fde071738dc2cb1e5183f7a03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Analysis</topic><topic>Biological response modifiers</topic><topic>Biopsy</topic><topic>Child</topic><topic>Child, Preschool</topic><topic>Data analysis</topic><topic>Distribution</topic><topic>Female</topic><topic>Gene expression</topic><topic>Genes</topic><topic>Genetic aspects</topic><topic>Genetic polymorphisms</topic><topic>Haplotypes</topic><topic>Health risk assessment</topic><topic>Humans</topic><topic>Infections</topic><topic>Interferon</topic><topic>Interferon gamma Receptor</topic><topic>Interferon-gamma - genetics</topic><topic>Laboratories</topic><topic>Leishmaniasis, Cutaneous - etiology</topic><topic>Leishmaniasis, Cutaneous - genetics</topic><topic>Leishmaniasis, Visceral - complications</topic><topic>Leishmaniasis, Visceral - genetics</topic><topic>Lymphatic system</topic><topic>Malaria</topic><topic>Male</topic><topic>Medical research</topic><topic>Medicine, Experimental</topic><topic>Pan troglodytes</topic><topic>Parasites</topic><topic>Parasitic diseases</topic><topic>Pathogenesis</topic><topic>Polymorphism, Genetic</topic><topic>Population</topic><topic>Promoter Regions, Genetic</topic><topic>Rankings</topic><topic>Receptors, Interferon - genetics</topic><topic>RNA</topic><topic>RNA, Messenger - metabolism</topic><topic>Signal transduction</topic><topic>Skin</topic><topic>Skin - metabolism</topic><topic>Studies</topic><topic>Sudan - epidemiology</topic><topic>Tropical diseases</topic><topic>Tuberculosis</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Salih, Mohamed A M</creatorcontrib><creatorcontrib>Fakiola, Michaela</creatorcontrib><creatorcontrib>Abdelraheem, Mohamed H</creatorcontrib><creatorcontrib>Younis, Brima M</creatorcontrib><creatorcontrib>Musa, Ahmed M</creatorcontrib><creatorcontrib>ElHassan, Ahmed M</creatorcontrib><creatorcontrib>Blackwell, Jenefer M</creatorcontrib><creatorcontrib>Ibrahim, Muntaser E</creatorcontrib><creatorcontrib>Mohamed, Hiba S</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Gale In Context: Opposing Viewpoints</collection><collection>Gale In Context: Science</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Health and Safety Science Abstracts (Full archive)</collection><collection>Virology and AIDS Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Public Health Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ASFA: Aquatic Sciences and Fisheries Abstracts</collection><collection>Aquatic Science & Fisheries Abstracts (ASFA) 1: Biological Sciences & Living Resources</collection><collection>Aquatic Science & Fisheries Abstracts (ASFA) 3: Aquatic Pollution & Environmental Quality</collection><collection>Aquatic Science & Fisheries Abstracts (ASFA) Professional</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>BMC infectious diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Salih, Mohamed A M</au><au>Fakiola, Michaela</au><au>Abdelraheem, Mohamed H</au><au>Younis, Brima M</au><au>Musa, Ahmed M</au><au>ElHassan, Ahmed M</au><au>Blackwell, Jenefer M</au><au>Ibrahim, Muntaser E</au><au>Mohamed, Hiba S</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Insights into the possible role of IFNG and IFNGR1 in Kala-azar and Post Kala-azar Dermal Leishmaniasis in Sudanese patients</atitle><jtitle>BMC infectious diseases</jtitle><addtitle>BMC Infect Dis</addtitle><date>2014-12-03</date><risdate>2014</risdate><volume>14</volume><issue>1</issue><spage>662</spage><epage>662</epage><pages>662-662</pages><artnum>662</artnum><issn>1471-2334</issn><eissn>1471-2334</eissn><abstract>Little is known about the parasite/host factors that lead to Post Kala-azar Dermal Leishmaniasis (PKDL) in some visceral leishmaniasis (VL) patients after drug-cure. Studies in Sudan provide evidence for association between polymorphisms in the gene (IFNGR1) encoding the alpha chain of interferon-γ receptor type I and risk of PKDL. This study aimed to identify putative functional polymorphisms in the IFNGR1 gene, and to determine whether differences in expression of interferon-γ (IFNG) and IFNGR1 at the RNA level are associated with pathogenesis of VL and/or PKDL in Sudan.
Sanger sequencing was used to re-sequence 841 bp of upstream, exon1 and intron1 of the IFNGR1 gene in DNA from 30 PKDL patients. LAGAN and SYNPLOT bioinformatics tools were used to compare human, chimpanzee and dog sequences to identify conserved noncoding sequences carrying putative regulatory elements. The relative expression of IFNG and IFNGR1 in paired pre- and post-treatment RNA samples from the lymph nodes of 24 VL patients, and in RNA samples from skin biopsies of 19 PKDL patients, was measured using real time PCR. Pre- versus post-treatment expression was evaluated statistically using the nonparametric Wilcoxon matched pairs signed-rank test.
Ten variants were identified in the 841 bp of sequence, four of which are novel polymorphisms at -77A/G, +10 C/T, +18C/T and +91G/T relative to the IFNGR1 initiation site. A cluster of conserved non-coding sequences with putative regulatory variants was identified in the distal promoter of IFNGR1. Variable expression of IFNG was detected in lymph node aspirates of VL patients before treatment, with a marked reduction (P = 0.006) in expression following treatment. IFNGR1 expression was also variable in lymph node aspirates from VL patients, with no significant reduction in expression with treatment. IFNG expression was undetectable in the skin biopsies of PKDL cases, while IFNGR1 expression was also uniformly low.
Uniformly low expression of IFN and IFNGR1 in PKDL skin biopsies could explain parasite persistence and is consistent with prior demonstration of genetic association with IFNGR1 polymorphisms. Identification of novel potentially functional rare variants at IFNGR1 makes an important general contribution to knowledge of rare variants of potential relevance in this Sudanese population.</abstract><cop>England</cop><pub>BioMed Central Ltd</pub><pmid>25466928</pmid><doi>10.1186/s12879-014-0662-5</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1471-2334 |
ispartof | BMC infectious diseases, 2014-12, Vol.14 (1), p.662-662, Article 662 |
issn | 1471-2334 1471-2334 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4265480 |
source | MEDLINE; DOAJ Directory of Open Access Journals; EZB-FREE-00999 freely available EZB journals; PubMed Central; SpringerLink Journals - AutoHoldings; PubMed Central Open Access; Springer Nature OA Free Journals |
subjects | Adolescent Adult Analysis Biological response modifiers Biopsy Child Child, Preschool Data analysis Distribution Female Gene expression Genes Genetic aspects Genetic polymorphisms Haplotypes Health risk assessment Humans Infections Interferon Interferon gamma Receptor Interferon-gamma - genetics Laboratories Leishmaniasis, Cutaneous - etiology Leishmaniasis, Cutaneous - genetics Leishmaniasis, Visceral - complications Leishmaniasis, Visceral - genetics Lymphatic system Malaria Male Medical research Medicine, Experimental Pan troglodytes Parasites Parasitic diseases Pathogenesis Polymorphism, Genetic Population Promoter Regions, Genetic Rankings Receptors, Interferon - genetics RNA RNA, Messenger - metabolism Signal transduction Skin Skin - metabolism Studies Sudan - epidemiology Tropical diseases Tuberculosis Young Adult |
title | Insights into the possible role of IFNG and IFNGR1 in Kala-azar and Post Kala-azar Dermal Leishmaniasis in Sudanese patients |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T03%3A18%3A01IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Insights%20into%20the%20possible%20role%20of%20IFNG%20and%20IFNGR1%20in%20Kala-azar%20and%20Post%20Kala-azar%20Dermal%20Leishmaniasis%20in%20Sudanese%20patients&rft.jtitle=BMC%20infectious%20diseases&rft.au=Salih,%20Mohamed%20A%20M&rft.date=2014-12-03&rft.volume=14&rft.issue=1&rft.spage=662&rft.epage=662&rft.pages=662-662&rft.artnum=662&rft.issn=1471-2334&rft.eissn=1471-2334&rft_id=info:doi/10.1186/s12879-014-0662-5&rft_dat=%3Cgale_pubme%3EA539574900%3C/gale_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1635977426&rft_id=info:pmid/25466928&rft_galeid=A539574900&rfr_iscdi=true |